• 목록
• 게시판 리스트 옵션
  • 수정
  • 삭제

Pragmatic Free Trial Meta

Pragmatic Free Trail Meta is an open data platform that enables research into pragmatic trials. It collects and shares cleaned trial data and ratings using PRECIS-2 permitting multiple and varied meta-epidemiological research studies to examine the effects of treatment across trials that have different levels of pragmatism as well as other design features.

Background

Pragmatic studies provide real-world evidence that can be used to make clinical decisions. The term "pragmatic" however, is used inconsistently and its definition and measurement need further clarification. Pragmatic trials are intended to inform clinical practices and policy decisions rather than verify a physiological hypothesis or clinical hypothesis. A pragmatic study should strive to be as close as it is to actual clinical practices which include the recruitment of participants, setting, designing, delivery and implementation of interventions, determining and analysis outcomes, and primary analysis. This is a significant difference between explanatory trials, as defined by Schwartz & Lellouch1 which are designed to confirm the hypothesis in a more thorough way.

Trials that are truly pragmatic must be careful not to blind patients or healthcare professionals as this could cause bias in the estimation of the effect of treatment. Practical trials also involve patients from various healthcare settings to ensure that their results can be generalized to the real world.

Furthermore the focus of pragmatic trials should be on outcomes that are important to patients, such as quality of life or functional recovery. This is particularly important in trials that require invasive procedures or have potentially harmful adverse impacts. The CRASH trial29 compared a 2-page report with an electronic monitoring system for hospitalized patients with chronic cardiac failure. The catheter trial28 however was based on symptomatic catheter-related urinary tract infection as the primary outcome.

In addition to these aspects, pragmatic trials should minimize the trial's procedures and data collection requirements in order to reduce costs. Finaly the aim of pragmatic trials is to make their results as relevant to actual clinical practice as is possible. This can be accomplished by ensuring that their primary analysis is based on an intention-to treat approach (as described within CONSORT extensions).

Despite these requirements, a number of RCTs with features that challenge pragmatism have been incorrectly self-labeled pragmatic and published in journals of all types. This could lead to misleading claims of pragmatism, and the usage of the term must be standardized. The creation of the PRECIS-2 tool, which provides an objective standard for assessing practical features is a good initial step.

Methods

In a practical trial the goal is to inform policy or clinical decisions by demonstrating how the intervention can be integrated into everyday routine care. Explanatory trials test hypotheses concerning the causal-effect relationship in idealized environments. Therefore, pragmatic trials might have less internal validity than explanatory trials, and could be more susceptible to bias in their design, conduct and analysis. Despite their limitations, pragmatic research can be a valuable source of data for making decisions within the healthcare context.

The PRECIS-2 tool evaluates an RCT on 9 domains, with scores ranging from 1 to 5 (very pragmatic). In this study, the recruitment, organisation, flexibility: delivery, flexible adherence and follow-up domains scored high scores, however the primary outcome and the method for missing data fell below the pragmatic limit. This suggests that it is possible to design a trial using high-quality pragmatic features, without compromising the quality of its outcomes.

However, it is difficult to assess how pragmatic a particular trial really is because pragmaticity is not a definite quality; certain aspects of a trial can be more pragmatic than others. A trial's pragmatism could be affected by changes to the protocol or logistics during the trial. Additionally 36% of 89 pragmatic trials identified by Koppenaal et al were placebo-controlled or conducted prior to licensing, and the majority were single-center. They aren't in line with the standard practice, and can only be called pragmatic if their sponsors accept that such trials are not blinded.

Furthermore, a common feature of pragmatic trials is that researchers attempt to make their findings more meaningful by analysing subgroups of the trial. This can result in unbalanced analyses that have less statistical power. This increases the risk of missing or misdetecting differences in the primary outcomes. In the case of the pragmatic trials included in this meta-analysis this was a significant problem because the secondary outcomes were not adjusted to account for variations in the baseline covariates.

Additionally, studies that are pragmatic can pose difficulties in the collection and interpretation of safety data. This is because adverse events are usually self-reported and are prone to delays in reporting, inaccuracies, or coding variations. It is crucial to improve the quality and accuracy of the outcomes in these trials.

Results

While the definition of pragmatism does not require that all clinical trials be 100% pragmatist, there are benefits when incorporating pragmatic components into trials. These include:

Incorporating routine patients, 프라그마틱 슬롯 팁 프라그마틱 슬롯 무료 하는법 (stay with me) the results of the trial can be more quickly translated into clinical practice. However, pragmatic trials be a challenge. The right kind of heterogeneity for instance, can help a study expand its findings to different patients or settings. However, the wrong type can decrease the sensitivity of the test and, consequently, reduce a trial's power to detect small treatment effects.

A variety of studies have attempted to categorize pragmatic trials using various definitions and scoring methods. Schwartz and Lellouch1 developed a framework to differentiate between explanation studies that support a physiological hypothesis or clinical hypothesis and pragmatic studies that help inform the selection of appropriate treatments in real world clinical practice. Their framework comprised nine domains, each scored on a scale ranging from 1-5, with 1 indicating more lucid and 5 indicating more practical. The domains were recruitment setting, setting, intervention delivery, flexible adherence, follow-up and primary analysis.

The original PRECIS tool3 was based on a similar scale and domains. Koppenaal and colleagues10 developed an adaptation of this assessment, dubbed the Pragmascope that was simpler to use in systematic reviews. They found that pragmatic reviews scored higher in most domains, but scored lower in the primary analysis domain.

This distinction in the main analysis domain could be explained by the fact that most pragmatic trials analyse their data in the intention to treat way while some explanation trials do not. The overall score for pragmatic systematic reviews was lower when the areas of management, flexible delivery and following-up were combined.

It is crucial to keep in mind that a study that is pragmatic does not mean a low-quality trial. In fact, there is an increasing number of clinical trials that employ the word 'pragmatic,' either in their abstracts or titles (as defined by MEDLINE however it is not precise nor sensitive). The use of these terms in titles and abstracts could suggest a greater awareness of the importance of pragmatism but it is unclear whether this is manifested in the content of the articles.

Conclusions

In recent years, pragmatic trials have been increasing in popularity in research because the value of real-world evidence is increasingly recognized. They are clinical trials randomized that evaluate real-world alternatives to care instead of experimental treatments in development. They involve patients which are more closely resembling the patients who receive routine care, they use comparisons that are commonplace in practice (e.g. existing drugs) and depend on participants' self-reports of outcomes. This method is able to overcome the limitations of observational research like the biases that are associated with the reliance on volunteers and the limited availability and coding variations in national registries.

Pragmatic trials also have advantages, like the ability to leverage existing data sources and a greater probability of detecting meaningful differences than traditional trials. However, pragmatic tests may have some limitations that limit their validity and generalizability. For example, participation rates in some trials may be lower than expected due to the healthy-volunteer influence and incentives to pay or compete for participants from other research studies (e.g. industry trials). The requirement to recruit participants quickly limits the sample size and the impact of many pragmatic trials. In addition certain pragmatic trials don't have controls to ensure that the observed differences are not due to biases in trial conduct.

The authors of the Pragmatic Free Trial Meta identified RCTs that were published between 2022 and 2022 that self-described as pragmatic. They assessed pragmatism by using the PRECIS-2 tool, which consists of the domains eligibility criteria and recruitment criteria, as well as flexibility in adherence to intervention, and follow-up. They discovered that 14 trials scored highly pragmatic or pragmatic (i.e. scoring 5 or more) in at least one of these domains.

Trials that have high pragmatism scores tend to have more criteria for eligibility than traditional RCTs. They also have patients from a variety of hospitals. The authors argue that these characteristics could make pragmatic trials more meaningful and relevant to daily practice, 프라그마틱 정품 슬롯 하는법 - index - but they do not necessarily guarantee that a trial using a pragmatic approach is free from bias. Moreover, the pragmatism of trials is not a definite characteristic; a pragmatic trial that doesn't possess all the characteristics of a explanatory trial may yield reliable and relevant results.